Nat Commun:我国急性腹泻的病原学、流行病学和临床特征研究

2021-05-04 haibei MedSci原创

最近,研究人员在Nature Communications杂志发文,报告了入选该分析的152,792名合格患者的病原学、流行病学和临床特征。

尽管人们已经在环境卫生状况和公共卫生意识方面取得了重大进展,但腹泻仍然是全世界疾病负担的主要原因之一。2016年,全世界因腹泻而发生的病例超过44亿,死亡人数超过160万。腹泻在生命损失的常见原因中排名第八,造成了大量的医疗和保健费用,对社会的经济影响很大。

有证据表明,腹泻病是导致儿科发病率和死亡率的主要因素,特别是在低收入和中等收入国家(LMICs)。2017年,全球5岁以下儿童因腹泻死亡的人数超过50万,其中88%发生在南亚和撒哈拉以南的非洲。

急性腹泻的病因在不同地区有所不同,取决于经济发展、当地气候和地理环境。更好地了解急性腹泻的流行病学、病因学和季节性,对规划和采取有针对性的预防措施以及抗菌治疗很有价值。

2009-2018年间,我国对全年龄段的急性腹泻患者进行了全国性的前瞻性监测。最近,研究人员在Nature Communications杂志发文,报告了入选该分析的152,792名合格患者的病原学、流行病学和临床特征。

 2009-2018年中国大陆各年龄段腹泻患者肠道病原体的病原谱和合并感染模式

结果显示,轮状病毒A和诺如病毒是在患者中检测到的两种主要病毒病原体,其次是腺病毒和天疱疮病毒。腹泻性大肠杆菌和非伤寒沙门氏菌是两种主要的细菌病原体,其次是志贺氏菌和副溶血性弧菌。

年龄小于5岁的患者的病毒性病原体总体阳性率较高,而细菌性病原体在18-45岁的患者中更常见。此外,连接点分析显示了特定年龄段的阳性率,以及个别病原体的阳性率如何变化。

因此,该研究结果填补了中国腹泻患者的肠道病原体分布如何变化的关键空白。这有助于在临床实践中更好地确定主要的腹泻病原体候选诊断,并更有针对性地应用预防和控制措施。

 

原始出处:

Li-Ping Wang et al. Etiological, epidemiological, and clinical features of acute diarrhea in China. Nature Communications (2021). 

 

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1885128, encodeId=3d62188512844, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Oct 12 06:41:34 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1842972, encodeId=02ea18429e2ea, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Tue Aug 17 14:41:34 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2087979, encodeId=ac10208e979a2, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Tue Nov 23 09:41:34 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411386, encodeId=266014113865c, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu May 06 05:41:34 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586682, encodeId=55ae1586682ed, content=<a href='/topic/show?id=fedfe08121c' target=_blank style='color:#2F92EE;'>#病原学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70812, encryptionId=fedfe08121c, topicName=病原学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70ff17366145, createdName=gjsgj, createdTime=Thu May 06 05:41:34 CST 2021, time=2021-05-06, status=1, ipAttribution=)]
    2021-10-12 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1885128, encodeId=3d62188512844, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Oct 12 06:41:34 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1842972, encodeId=02ea18429e2ea, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Tue Aug 17 14:41:34 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2087979, encodeId=ac10208e979a2, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Tue Nov 23 09:41:34 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411386, encodeId=266014113865c, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu May 06 05:41:34 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586682, encodeId=55ae1586682ed, content=<a href='/topic/show?id=fedfe08121c' target=_blank style='color:#2F92EE;'>#病原学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70812, encryptionId=fedfe08121c, topicName=病原学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70ff17366145, createdName=gjsgj, createdTime=Thu May 06 05:41:34 CST 2021, time=2021-05-06, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1885128, encodeId=3d62188512844, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Oct 12 06:41:34 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1842972, encodeId=02ea18429e2ea, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Tue Aug 17 14:41:34 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2087979, encodeId=ac10208e979a2, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Tue Nov 23 09:41:34 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411386, encodeId=266014113865c, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu May 06 05:41:34 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586682, encodeId=55ae1586682ed, content=<a href='/topic/show?id=fedfe08121c' target=_blank style='color:#2F92EE;'>#病原学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70812, encryptionId=fedfe08121c, topicName=病原学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70ff17366145, createdName=gjsgj, createdTime=Thu May 06 05:41:34 CST 2021, time=2021-05-06, status=1, ipAttribution=)]
    2021-11-23 liuli5079
  4. [GetPortalCommentsPageByObjectIdResponse(id=1885128, encodeId=3d62188512844, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Oct 12 06:41:34 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1842972, encodeId=02ea18429e2ea, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Tue Aug 17 14:41:34 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2087979, encodeId=ac10208e979a2, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Tue Nov 23 09:41:34 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411386, encodeId=266014113865c, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu May 06 05:41:34 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586682, encodeId=55ae1586682ed, content=<a href='/topic/show?id=fedfe08121c' target=_blank style='color:#2F92EE;'>#病原学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70812, encryptionId=fedfe08121c, topicName=病原学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70ff17366145, createdName=gjsgj, createdTime=Thu May 06 05:41:34 CST 2021, time=2021-05-06, status=1, ipAttribution=)]
    2021-05-06 xugumin
  5. [GetPortalCommentsPageByObjectIdResponse(id=1885128, encodeId=3d62188512844, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Tue Oct 12 06:41:34 CST 2021, time=2021-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1842972, encodeId=02ea18429e2ea, content=<a href='/topic/show?id=112222886b8' target=_blank style='color:#2F92EE;'>#临床特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22886, encryptionId=112222886b8, topicName=临床特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Tue Aug 17 14:41:34 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2087979, encodeId=ac10208e979a2, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Tue Nov 23 09:41:34 CST 2021, time=2021-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411386, encodeId=266014113865c, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Thu May 06 05:41:34 CST 2021, time=2021-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1586682, encodeId=55ae1586682ed, content=<a href='/topic/show?id=fedfe08121c' target=_blank style='color:#2F92EE;'>#病原学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70812, encryptionId=fedfe08121c, topicName=病原学)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70ff17366145, createdName=gjsgj, createdTime=Thu May 06 05:41:34 CST 2021, time=2021-05-06, status=1, ipAttribution=)]
    2021-05-06 gjsgj

相关资讯

Am J Gastroenterol:依鲁沙多林可有效且安全的治疗罗哌酰胺治疗后效果不佳的肠易激综合征患者的腹泻症状

肠易激综合征伴腹泻(IBS-D)是一种功能性胃肠道疾病,患者往往在缓解症状的基础上采取干预措施,但其有效治疗方案仍然有限。近日,发表于Am J Gastroenterol的一项随机对照研究结果证实依鲁

如何安全食用冷冻冰鲜食品?专家建议这样做

冷冻冰鲜食品是我们平时购买、食用频率较高的食物种类之一,但产品在养殖、宰杀、运输、销售等环节中可能会沾染细菌、病毒、甚至寄生虫,因此该类食品安全问题也尤为引人关注。

J Clin Gastroenterol:益生菌酸奶预防成年人抗生素相关的腹泻

使用抗生素后的腹泻是临床上经常出现的问题。益生菌对住院成人人群预防AAD的作用仍不清楚。本研究旨在评估补充益生菌的酸奶对住院患者抗生素相关性腹泻(AAD)的预防效果,研究结果已在线发表于J Clin

World J Gastroenterol:鼠李糖乳杆菌GG可有效治疗小儿急性腹泻,宜早期干预

腹泻是导致全球儿童发病和死亡的主要感染性原因。既往临床试验显示鼠李糖乳杆菌GG ATCC 53013(LGG)可用于治疗腹泻。然而,最近的随机对照试验(RCTs)并不支持LGG的有益效果。近日,发表于

Nat Commun:基于微生物群的标志物预测艰难梭菌感染

最近,研究人员在一项前瞻性的90天队列研究中,分析了抗生素治疗前后和腹泻发病时CDI风险增加的住院患者的肠道微生物群。

Lancet Infect Dis:志贺氏菌属SF2a-TT15疫苗I期临床研究获得成功

SF2a-TT15疫苗耐受性良好,具有预防由志贺氏菌属感染导致的严重腹泻的潜力